{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T16:25:23Z","timestamp":1789575923012,"version":"build-2803163510"},"reference-count":26,"publisher":"SAGE Publications","issue":"8","license":[{"start":{"date-parts":[[2024,6,18]],"date-time":"2024-06-18T00:00:00Z","timestamp":1718668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"funder":[{"DOI":"10.13039\/100005269","name":"Center for Substance Abuse Prevention","doi-asserted-by":"publisher","award":["75S20123P00003"],"award-info":[{"award-number":["75S20123P00003"]}],"id":[{"id":"10.13039\/100005269","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["J Psychopharmacol"],"published-print":{"date-parts":[[2024,8]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Voter initiatives in Oregon and Colorado authorize legal frameworks for supervised psilocybin services, but no measures monitor safety or outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aims:<\/jats:title>\n                    <jats:p>To develop core measures of best practices.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>A three-phase e-Delphi process recruited 36 experts with 5 or more years\u2019 experience facilitating psilocybin experiences in various contexts (e.g., ceremonial settings, indigenous practices, clinical trials), or other pertinent psilocybin expertise. Phase I, an on-line survey with qualitative, open-ended text responses, generated potential measures to assess processes, outcomes, and structure reflecting high quality psilocybin services. In Phase II, experts used seven-point Likert scales to rate the importance and feasibility of the Phase I measures. Measures were priority ranked. Qualitative interviews and analysis in Phase III refined top-rated measures.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Experts ( n\u2009=\u200936; 53% female; 71% white; 56% heterosexual) reported currently providing psilocybin services (64%) for a mean of 15.2 [SD 13.1] years, experience with indigenous psychedelic practices (67%), and\/or conducting clinical trials (36%). Thematic analysis of Phase I responses yielded 55 candidate process measures (e.g., preparatory hours with client, total dose of psilocybin administered, documentation of touch\/sexual boundaries), outcome measures (e.g., adverse events, well-being, anxiety\/depression symptoms), and structure measures (e.g., facilitator training in trauma informed care, referral capacity for medical\/psychiatric issues). In Phase II and III, experts prioritized a core set of 11 process, 11 outcome, and 17 structure measures that balanced importance and feasibility.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Service providers and policy makers should consider standardizing core measures developed in this study to monitor the safety, quality, and outcomes of community-based psilocybin services.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/02698811241257839","type":"journal-article","created":{"date-parts":[[2024,6,18]],"date-time":"2024-06-18T07:07:58Z","timestamp":1718694478000},"page":"761-768","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":17,"title":["Developing the Open Psychedelic Evaluation Nexus consensus measures for assessment of supervised psilocybin services: An e-Delphi study"],"prefix":"10.1177","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5556-3597","authenticated-orcid":false,"given":"Philip Todd","family":"Korthuis","sequence":"first","affiliation":[{"name":"Oregon Health & Science University, Portland, OR, USA"},{"name":"The Open Psychedelic Evaluation Nexus (OPEN), Portland, OR, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3063-7881","authenticated-orcid":false,"given":"Kim","family":"Hoffman","sequence":"additional","affiliation":[{"name":"Oregon Health & Science University, Portland, OR, USA"},{"name":"The Open Psychedelic Evaluation Nexus (OPEN), Portland, OR, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrianne R.","family":"Wilson-Poe","sequence":"additional","affiliation":[{"name":"The Open Psychedelic Evaluation Nexus (OPEN), Portland, OR, USA"},{"name":"Legacy Research Institute, Legacy Health, Portland, OR, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason B.","family":"Luoma","sequence":"additional","affiliation":[{"name":"The Open Psychedelic Evaluation Nexus (OPEN), Portland, OR, USA"},{"name":"Portland Psychotherapy Clinic, Research, & Training Center, Portland, OR, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alissa","family":"Bazinet","sequence":"additional","affiliation":[{"name":"The Open Psychedelic Evaluation Nexus (OPEN), Portland, OR, USA"},{"name":"Sequoia Center, Portland, OR, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kellie","family":"Pertl","sequence":"additional","affiliation":[{"name":"Oregon Health & Science University, Portland, OR, USA"},{"name":"The Open Psychedelic Evaluation Nexus (OPEN), Portland, OR, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David L.","family":"Morgan","sequence":"additional","affiliation":[{"name":"Department of Sociology, Portland State University, Portland, OR, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan R.","family":"Cook","sequence":"additional","affiliation":[{"name":"Oregon Health & Science University, Portland, OR, USA"},{"name":"The Open Psychedelic Evaluation Nexus (OPEN), Portland, OR, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarann","family":"Bielavitz","sequence":"additional","affiliation":[{"name":"Oregon Health & Science University, Portland, OR, USA"},{"name":"The Open Psychedelic Evaluation Nexus (OPEN), Portland, OR, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renae","family":"Myers","sequence":"additional","affiliation":[{"name":"Oregon Health & Science University, Portland, OR, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-8332-0321","authenticated-orcid":false,"given":"Robert Cameron","family":"Wolf","sequence":"additional","affiliation":[{"name":"Subtance Abuse and Mental Health Services Administration, Center for Substance Abuse Prevention, Rockville, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis","family":"McCarty","sequence":"additional","affiliation":[{"name":"Oregon Health & Science University, Portland, OR, USA"},{"name":"The Open Psychedelic Evaluation Nexus (OPEN), Portland, OR, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher S.","family":"Stauffer","sequence":"additional","affiliation":[{"name":"Oregon Health & Science University, Portland, OR, USA"},{"name":"The Open Psychedelic Evaluation Nexus (OPEN), Portland, OR, USA"},{"name":"Portland VA Medical Center, Portland, OR, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2024,6,18]]},"reference":[{"key":"bibr1-02698811241257839","doi-asserted-by":"publisher","DOI":"10.1370\/afm.1139"},{"key":"bibr2-02698811241257839","unstructured":"ATLAS.ti Scientific Software Development GmbH (2023) ATLAS.ti Mac (version 23.2.1) [Qualitative data analysis software]. Available at: https:\/\/atlasti.com."},{"key":"bibr3-02698811241257839","doi-asserted-by":"publisher","DOI":"10.1177\/0269881116678781"},{"key":"bibr4-02698811241257839","doi-asserted-by":"publisher","DOI":"10.1016\/j.mex.2021.101401"},{"key":"bibr5-02698811241257839","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2022.109214"},{"key":"bibr6-02698811241257839","doi-asserted-by":"publisher","DOI":"10.1016\/j.techfore.2019.07.002"},{"key":"bibr7-02698811241257839","doi-asserted-by":"publisher","DOI":"10.1191\/1478088706qp063oa"},{"key":"bibr8-02698811241257839","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyg.2022.866018"},{"key":"bibr9-02698811241257839","doi-asserted-by":"publisher","DOI":"10.2307\/3348969"},{"key":"bibr10-02698811241257839","volume-title":"The Definition of Quality and Approaches to Its Assessment","author":"Donabedian A","year":"1980"},{"key":"bibr11-02698811241257839","doi-asserted-by":"publisher","DOI":"10.1080\/02791072.2022.2125467"},{"key":"bibr12-02698811241257839","doi-asserted-by":"publisher","DOI":"10.1186\/s13063-021-05051-9"},{"key":"bibr13-02698811241257839","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2648.2006.03716.x"},{"key":"bibr14-02698811241257839","doi-asserted-by":"publisher","DOI":"10.1111\/cpsp.12268"},{"key":"bibr15-02698811241257839","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-5906.2012.01685.x"},{"key":"bibr16-02698811241257839","author":"MAPS Public Benefit Corporation (2023)","journal-title":"MAPS Code of Ethics for Psychedelic Psychotherapy"},{"key":"bibr17-02698811241257839","volume-title":"Focus Groups as Qualitative Research","author":"Morgan DL","year":"1996"},{"key":"bibr18-02698811241257839","doi-asserted-by":"publisher","DOI":"10.1177\/1049732313501889"},{"key":"bibr19-02698811241257839","unstructured":"Multidisciplinary Association for Psychedelic Studies (2022) Available at: https:\/\/maps.org\/2019\/05\/24\/statement-public-announcement-of-ethical-violation-by-former-maps-sponsored-investigators\/."},{"key":"bibr20-02698811241257839","unstructured":"National Committee for Quality Assurance (2022) 2023 Quality rating system measure technical specifications. Available at: https:\/\/www.cms.gov\/files\/document\/2023-qrs-technical-specifications.pdf."},{"key":"bibr21-02698811241257839","unstructured":"Oregon Health Authority (2022) Ethical principles\/code of conduct for psilocybin facilitators. Available at: https:\/\/www.oregon.gov\/oha\/PH\/PREVENTIONWELLNESS\/Documents\/Ethical%20Principles-Code%20of%20Conduct%20for%20Jan%206%20Meeting%201-2-2022.pdf."},{"key":"bibr22-02698811241257839","doi-asserted-by":"publisher","DOI":"10.1177\/0022167817711304"},{"key":"bibr23-02698811241257839","doi-asserted-by":"publisher","DOI":"10.1186\/s12954-021-00489-1"},{"key":"bibr24-02698811241257839","unstructured":"QUARTZ (2022) Available at: https:\/\/qz.com\/1809184\/psychedelic-therapy-has-a-sexual-abuse-problem-3."},{"key":"bibr25-02698811241257839","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-015-0449-6"},{"key":"bibr26-02698811241257839","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2023.1968"}],"container-title":["Journal of Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/02698811241257839","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/02698811241257839","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/02698811241257839","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:11:44Z","timestamp":1777507904000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/02698811241257839"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,18]]},"references-count":26,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["10.1177\/02698811241257839"],"URL":"https:\/\/doi.org\/10.1177\/02698811241257839","relation":{},"ISSN":["0269-8811","1461-7285"],"issn-type":[{"value":"0269-8811","type":"print"},{"value":"1461-7285","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,18]]}}}